In this study, APP and APP/PS1 transgenic mice displayed fewer TUNEL-positive cells in the GCL following injection of NMDA than wild-type controls suggesting that deposition of Aβ may prevent activation of NMDA-receptor pathways and mediate retinal dysfunction in AD in this way. This evidence concerns the gene PSEN1 and Alzheimer disease.